ciprofloxacin has been researched along with Stevens-Johnson Syndrome in 22 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Serious adverse reactions reported with ciprofloxacin are rare with an incidence of 0." | 5.35 | Toxic epidermal necrolysis and agranulocytosis: rare adverse effects of ciprofloxacin. ( Ruxana, K; Upadya, GM, 2009) |
| "This survey considers 8 cases of toxic epidermal necrolysis diagnosed and treated in our clinic from 2003 to 2007." | 1.36 | Basic measures and systemic medical treatment of patients with toxic epidermal necrolysis. ( Hanken, I; Sander, CA; Schimmer, M, 2010) |
| " Serious adverse reactions reported with ciprofloxacin are rare with an incidence of 0." | 1.35 | Toxic epidermal necrolysis and agranulocytosis: rare adverse effects of ciprofloxacin. ( Ruxana, K; Upadya, GM, 2009) |
| "Toxic epidermal necrolysis (TEN), or Lyell's syndrome, is a fulminant bullous dermatitis." | 1.32 | Ciprofloxacin-induced toxic epidermal necrolysis in a patient with systemic lupus erythematosus. ( Jongen-Lavrencic, M; Schneeberger, PM; van der Hoeven, JG, 2003) |
| "Skin biopsy confirmed toxic epidermal necrolysis." | 1.32 | Ciprofloxacin-induced toxic epidermal necrolysis (TEN) in a nonagerian: a case report. ( Jones, H; Mandal, B; Singh, S; Steward, M, 2004) |
| "Toxic epidermal necrolysis (TEN) or Lyell's syndrome is a rare fulminating skin disease notorious for its rapidly progressive course and high mortality rate." | 1.28 | Plasma exchange (PE) treatment in drug-induced toxic epidermal necrolysis (TEN). ( Alexopoulos, E; Chrisomalis, F; Karpouzas, J; Koukoudis, P; Papadimitriou, M; Papadopoulou, D; Sakellariou, G; Skenteris, N; Tsakaris, D, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (40.91) | 18.2507 |
| 2000's | 9 (40.91) | 29.6817 |
| 2010's | 3 (13.64) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Mortazavi, H | 1 |
| Rostami, A | 1 |
| Firooz, A | 1 |
| Esmaili, N | 1 |
| Ghiasi, M | 1 |
| Lajevardi, V | 1 |
| Amirzargar, AA | 1 |
| Sheykhi, I | 1 |
| Khamesipour, A | 1 |
| Akhdar, M | 1 |
| Vural, S | 1 |
| Arakawa, A | 1 |
| Arakawa, Y | 1 |
| Prinz, JC | 1 |
| Moghaddam, S | 1 |
| Connolly, D | 1 |
| Okan, G | 1 |
| Yaylaci, S | 1 |
| Peker, O | 1 |
| Kaymakoglu, S | 1 |
| Saruc, M | 1 |
| Hanken, I | 1 |
| Schimmer, M | 1 |
| Sander, CA | 1 |
| Upadya, GM | 1 |
| Ruxana, K | 1 |
| Cholongitas, E | 1 |
| Georgousaki, C | 1 |
| Spyrou, S | 1 |
| Katsogridakis, K | 1 |
| Dasenaki, M | 1 |
| Hällgren, J | 1 |
| Tengvall-Linder, M | 1 |
| Persson, M | 1 |
| Wahlgren, CF | 1 |
| Jongen-Lavrencic, M | 1 |
| Schneeberger, PM | 1 |
| van der Hoeven, JG | 1 |
| Mandal, B | 1 |
| Steward, M | 1 |
| Singh, S | 1 |
| Jones, H | 1 |
| Famularo, G | 1 |
| Di Dona, B | 1 |
| Canzona, F | 1 |
| Girardelli, CR | 1 |
| Cruciani, G | 1 |
| Bhatia, RS | 1 |
| Gohel, DR | 1 |
| Oza, JJ | 1 |
| Kamili, MA | 1 |
| Ali, G | 1 |
| Rashid, S | 1 |
| Mansoor, A | 1 |
| Allaqaband, GQ | 1 |
| Win, A | 1 |
| Evers, ML | 1 |
| Chmel, H | 1 |
| Moshfeghi, M | 1 |
| Mandler, HD | 1 |
| Yerasi, AB | 1 |
| Oertel, MD | 1 |
| Livasy, CA | 1 |
| Kaplan, AM | 1 |
| Vélez, A | 1 |
| Moreno, JC | 1 |
| Kundu, AK | 1 |
| Tham, TC | 1 |
| Allen, G | 1 |
| Hayes, D | 1 |
| McGrady, B | 1 |
| Riddell, JG | 1 |
| Sakellariou, G | 1 |
| Koukoudis, P | 1 |
| Karpouzas, J | 1 |
| Alexopoulos, E | 1 |
| Papadopoulou, D | 1 |
| Chrisomalis, F | 1 |
| Skenteris, N | 1 |
| Tsakaris, D | 1 |
| Papadimitriou, M | 1 |
2 reviews available for ciprofloxacin and Stevens-Johnson Syndrome
| Article | Year |
|---|---|
Stevens-Johnson syndrome associated with ciprofloxacin: a review of adverse cutaneous events reported in Sweden as associated with this drug.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Anti-Infective Agents; Ciprofloxacin; Female; Humans | 2003 |
Ciprofloxacin-induced toxic epidermal necrolysis: a case report.
Topics: Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Fatal Outcome; Female; Humans; Leg Ulcer; Male; M | 1997 |
20 other studies available for ciprofloxacin and Stevens-Johnson Syndrome
| Article | Year |
|---|---|
Association between human leukocyte antigens and cutaneous adverse drug reactions to antiepileptics and antibiotics in the Iranian population.
Topics: Adult; Anti-Bacterial Agents; Anticonvulsants; Carbamazepine; Case-Control Studies; Ciprofloxacin; F | 2022 |
The therapeutic potential of TNF-α antagonists in toxic epidermal necrosis: insights from two cases and adverse event reports.
Topics: Adalimumab; Anti-Bacterial Agents; Ciprofloxacin; Dermatologic Agents; Etanercept; Female; Humans; M | 2018 |
Photo-induced Stevens-Johnson syndrome.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dermatitis, Phototoxic; Disease Progression; Female; Humans; S | 2014 |
Vanishing bile duct and Stevens-Johnson syndrome associated with ciprofloxacin treated with tacrolimus.
Topics: Adult; Bile Duct Diseases; Ciprofloxacin; Deglutition Disorders; Dysuria; Female; Humans; Immunosupp | 2008 |
Basic measures and systemic medical treatment of patients with toxic epidermal necrolysis.
Topics: Adult; Aged; Aged, 80 and over; Allopurinol; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antico | 2010 |
Toxic epidermal necrolysis and agranulocytosis: rare adverse effects of ciprofloxacin.
Topics: Administration, Oral; Adult; Agranulocytosis; Anti-Bacterial Agents; Anti-Infective Agents; Ciproflo | 2009 |
Stevens-Johnson syndrome related to ciprofloxacin, possibly enhanced by overadministration of levothyroxine.
Topics: Aged; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactio | 2009 |
Ciprofloxacin-induced toxic epidermal necrolysis in a patient with systemic lupus erythematosus.
Topics: Adult; Ciprofloxacin; Combined Modality Therapy; Disease Progression; Fatal Outcome; Female; Humans; | 2003 |
Ciprofloxacin-induced toxic epidermal necrolysis (TEN) in a nonagerian: a case report.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Fatal Outcome; Female; Humans; Steven | 2004 |
Etanercept for toxic epidermal necrolysis.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Etanercept; Humans; Immunoglobulin G; Immunologic Factors; Mal | 2007 |
Steven Johnson syndrome following a single dose of ciprofloxacin.
Topics: Administration, Oral; Adult; Ciprofloxacin; Drug Eruptions; Humans; Male; Stevens-Johnson Syndrome | 1994 |
Steven-Johnson's syndrome following single dose of ciprofloxacin.
Topics: Ciprofloxacin; Humans; Stevens-Johnson Syndrome | 1994 |
Ciprofloxacin induced Stevens-Johnson syndrome.
Topics: Ciprofloxacin; Female; Humans; Stevens-Johnson Syndrome | 1994 |
Stevens-Johnson syndrome presumably induced by ciprofloxacin.
Topics: Adult; Ciprofloxacin; Humans; Male; Penicillin G; Stevens-Johnson Syndrome; Streptococcal Infections | 1994 |
Ciprofloxacin-induced toxic epidermal necrolysis.
Topics: Administration, Oral; Adult; Ciprofloxacin; Female; Hospitals, University; Humans; Lupus Erythematos | 1993 |
Ciprofloxacin-induced toxic epidermal necrolysis.
Topics: Anti-Infective Agents; Ciprofloxacin; Fatal Outcome; Humans; Male; Stevens-Johnson Syndrome | 1996 |
Second case of ranitidine-related toxic epidermal necrolysis in a patient with idiopathic thrombocytopenic purpura.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Female; Fluid Therapy; Histamine H2 Antagonists; Humans | 2000 |
Ciprofloxacin-induced severe cutaneous reaction and haemolysis in a young adult.
Topics: Adolescent; Anemia, Hemolytic; Ciprofloxacin; Drug Eruptions; Glucosephosphate Dehydrogenase Deficie | 2000 |
Possible association between toxic epidermal necrolysis and ciprofloxacin.
Topics: Aged; Ciprofloxacin; Combined Modality Therapy; Humans; Male; Product Surveillance, Postmarketing; S | 1991 |
Plasma exchange (PE) treatment in drug-induced toxic epidermal necrolysis (TEN).
Topics: Aged; Allopurinol; Amoxicillin; Carbamazepine; Child; Ciprofloxacin; Humans; Male; Mefenamic Acid; M | 1991 |